+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 4Years - 8Years
All Genders
ID05361122

Evaluation of Neurodevelopmental Outcomes in Children Aged 4-8 Years Related to Gestational Xylitol Exposure in Malawi

Led by University of Washington · Updated on 2026-08-19

1000

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying neurodevelopmental outcomes in children aged 4 to 8 years in Malawi who were born to mothers participating in the Prevention of Prematurity and Xylitol PPaX trial. This study compares children exposed to maternal xylitol chewing gum during pregnancy to those without such exposure, focusing on cognitive, executive function, social-emotional, motor, and language development. The trial includes 1000 children divided equally between formerly preterm and term births, considering the impact of gestational xylitol exposure on these groups. The study does not involve new treatments but evaluates differences based on prior exposure to xylitol chewing gum during pregnancy. Children are stratified into four groups depending on preterm or term birth status and xylitol exposure. Neurodevelopmental assessments include the Malawi Developmental Assessment Tool MDAT, Kaufman Assessment Battery for Children-II KABC-II, EF Touch, Strengths and Difficulties Questionnaire SDQ, Anchor Items in Measuring Early Childhood Development AIM-ECD, and the International Development and Early Learning Assessment IDELA. Mothers may also be invited for anthropometric and oral health assessments. Participants will undergo one to two clinic visits within one month for neurodevelopmental assessments, hearing, vision, and dental evaluations. Researchers will measure cognitive scores, executive function, social-emotional outcomes, and motor skills using standardized tools. The primary outcome is the overall cognitive score based on the mental processing index. The study monitors these outcomes carefully to understand the effects of gestational xylitol exposure on child development up to age 8.

CONDITIONS

Brief Title

Prevention of Developmental Delay and Xylitol (PDDaX) Study

Research Team

G

Greg Valentine, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here